This year is very important and many key jobs are at stake with upcoming launches. Jez has good understanding what current management has promised to deliver in the past and now present. First question Jez thinks is are the current management leaders are in the right roles and what is the track record. Key people in Diabetes with Afrezza and the upcoming statin therapy will be closely watched. How Mangement is doing going into the summer will be of a major concern to Paris. Will Afrezza make money? Will Mangement finger point to sales as has been the custom over the years even with clearly botched management mistakes. Jez understands to get the most out of people is change how things are done in HR. A certain person has had way to much control and input and has been key in ruining trust and culture issues. Things are already in the works as all I can ask is to be patient. Things you want done don't happen overnight and lots of behind the scenes things are in motion. Eyes also are closely watching how things go in CV and Allergy. The auto injector has been a mess with too many errors to list here including a poor launch, and much blame shifting. The new statin therapy is for bridging to other therapies that are coming over next three years. Look for many of the VP's to be gone if this don't go well. Paris now has a better understanding after all of Chris V double talk to the board and blaming others for his strategy and his hiring of Ann W who wasn't the person for the job. I will post when I can as I've changed some grammar and sentence structure to not give any clues to my idenity.
55 Insider for 2015
Aucun commentaire:
Enregistrer un commentaire